What is the catalog number for JFD00244?

The catalog number for JFD00244 is HY-108986.

What sizes are available for JFD00244?

JFD00244 is available in the following size(s): 1 mg, 5 mg, 10 mM - 1 mL, 10 mg, 25 mg, 50 mg, 100 mg.

How many pack sizes does JFD00244 come in?

JFD00244 is available in 7 different pack sizes.

Is JFD00244 in stock?

JFD00244 is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures JFD00244?

JFD00244 is manufactured by QuantiMol.

What is the estimated delivery time for JFD00244?

Estimated delivery time for JFD00244 is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for JFD00244?

The safety data sheet for JFD00244 is available here: http://file.medchemexpress.com/batch_PDF/HY-108986/JFD00244-SDS-MedChemExpress.pdf.

JFD00244

JFD00244 is a sirtuin 2 (SIRT2) inhibitor, with anti-tumor effect. JFD00244 is also a Nsp-16 inhibitor against SARS-CoV-2[1][2].

Product Specifications

CAS Number

96969-83-4

UNSPSC

12352005

Hazard Statement

H410

Target

SARS-CoV; Sirtuin

Type

Reference compound

Related Pathways

Anti-infection; Cell Cycle/DNA Damage; Epigenetics

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/jfd00244.html

Purity

99.40

Solubility

DMSO : 50 mg/mL (ultrasonic) |H2O : < 0.1 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

O=C1C2=C(C=CC=C2)C(C3=C(NCCC4=CC=C(O)C=C4)C=CC(NCCC5=CC=C(O)C=C5)=C13)=O

Molecular Formula

C30H26N2O4

Molecular Weight

478.54

Precautions

H410

References & Citations

[1]Ciarlo C, A chemical screen in zebrafish embryonic cells establishes that Akt activation is required for neural crest development. Elife. 2017 Aug 23;6. pii: e29145.|[2]Shankar U, et al. Potential Drugs Targeting Nsp16 Protein May Corroborates a Promising Approach to Combat SARSCoV-2 Virus. ChemRxiv. Cambridge: Cambridge Open Engage; 2020; This content is a preprint and has not been peer-reviewed. |[3]Kim Dae Jung, et al. Pharmaceutical composition for preventing and treating prostate cancer: World Intellectual Property Organization, WO2014065537[P]. 2014-05-01.